Weidong Jiang

Title: Weidong Jiang: Innovator in Antibody Development

Introduction

Weidong Jiang is a notable inventor based in Sunnyvale, CA. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. His work focuses on innovative solutions for treating lymphoma, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Weidong Jiang holds a patent for "Variant Fc regions." This invention provides humanized anti-CD20 antibodies that include a human IgG1 Fc region with specific amino acid modifications. The patent details the use of these antibodies, which comprise an isoleucine at position 247 and a glutamine at position 339. Additionally, it includes nucleic acids encoding the antibodies and methods for their application in treating lymphoma. The invention also encompasses compositions containing the antibodies and methods for their production. He has 1 patent to his name.

Career Highlights

Weidong Jiang is currently employed at Applied Molecular Evolution, where he continues to push the boundaries of antibody research. His work has been instrumental in developing therapies that can significantly impact patient outcomes in oncology.

Collaborations

Throughout his career, Weidong has collaborated with talented individuals such as Barrett Allan and Ying Tang. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.

Conclusion

Weidong Jiang's contributions to antibody development exemplify the impact of innovative thinking in biotechnology. His patent for humanized anti-CD20 antibodies represents a significant advancement in the treatment of lymphoma. His ongoing work at Applied Molecular Evolution continues to inspire progress in medical research.